Systemic Glucocorticoid Regimen for Acute Gout
For acute gout flares, use oral prednisone/prednisolone 30-35 mg daily (or 0.5 mg/kg/day) for 3-5 days then stop, or alternatively continue for 2-5 days at full dose followed by a 7-10 day taper. 1, 2
Oral Corticosteroid Dosing
The most recent EULAR 2016 guidelines 1 recommend:
- 30-35 mg/day of prednisolone equivalent for 3-5 days as a first-line option for acute flares
- This can be given without tapering if the duration is short (3-5 days)
The ACR 2012 guidelines 2 provide additional flexibility:
- Starting dose: 0.5 mg/kg/day (approximately 30-40 mg for average adult)
- Duration options:
- 5-10 days at full dose, then discontinue abruptly, OR
- 2-5 days at full dose, then taper over 7-10 days before discontinuation
- Methylprednisolone dose pack is also acceptable based on provider/patient preference
The choice between abrupt discontinuation versus taper depends on treatment duration: Short courses (3-5 days) can be stopped abruptly without rebound, while longer courses (5-10 days) may benefit from tapering to prevent flare recurrence.
Intramuscular Corticosteroid Option
For patients unable to take oral medications or requiring rapid onset, intramuscular triamcinolone acetonide 60 mg as a single dose is appropriate, followed by oral prednisone/prednisolone. 2, 3
The ACR guidelines note there was no consensus on using IM triamcinolone as monotherapy without oral follow-up 2. The FDA label 3 specifies:
- Usual IM dose range: 40-80 mg (adjusted based on response)
- Some patients controlled on as low as 20 mg
- Must inject deeply into gluteal muscle to avoid subcutaneous fat atrophy
Intra-articular Triamcinolone
Intra-articular corticosteroid injection is appropriate for monoarticular or oligoarticular gout (1-2 large joints), with dosing based on joint size. 1, 2
When to Use Intra-articular Injection:
- 1-2 large joints involved (knee, ankle, shoulder)
- Patient preference or when oral medications contraindicated
- Can be combined with oral corticosteroids, NSAIDs, or colchicine 2
Dosing by Joint Size:
The ACR guidelines 2 recommend dosing based on joint size, while the FDA label 3 specifies:
- Small joints: 2.5-5 mg
- Large joints: 5-15 mg
- Usual range for adults: up to 10 mg for smaller areas, up to 40 mg for larger areas
- Single injections into multiple joints up to total of 80 mg have been used
Critical Precautions:
- Rule out septic arthritis before injection - neither intra-articular nor systemic steroids should be used if infection suspected 4
- Aspirate excessive synovial fluid before injection to aid pain relief and prevent steroid dilution 3
- Use strict aseptic technique 3
- Inject into joint space, not surrounding tissues, to avoid tissue atrophy 3
Key Clinical Considerations
Corticosteroids are particularly valuable when:
- NSAIDs contraindicated (renal impairment, GI bleeding risk, cardiovascular disease)
- Colchicine contraindicated (severe renal impairment, drug interactions with CYP3A4/P-glycoprotein inhibitors like clarithromycin, cyclosporine)
- Polyarticular involvement (≥3 joints)
- Patient unable to take oral medications (use IM route)
Common pitfall: The 2006 EULAR guidelines 4 note that while intra-articular steroids are widely used and effective in clinical practice, they lack RCT evidence. However, one uncontrolled trial showed complete pain relief (VAS 88→0) within 48 hours in all 19 patients with 10 mg triamcinolone acetonide, with no side effects or rebound attacks.
Avoid long-term corticosteroid use - the regimens above are specifically for acute flare management only. The ACP 2017 guidelines 5 emphasize that long-term corticosteroid use causes dose- and duration-dependent adverse effects affecting multiple organ systems (dysphoria, hyperglycemia, immune suppression, fluid retention).